Last reviewed · How we verify
Reb blood cell transfusion
At a glance
| Generic name | Reb blood cell transfusion |
|---|---|
| Sponsor | Bristol-Myers Squibb |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study of Incidence, Treatment Patterns, and Outcomes in Transfusion-dependent Lower-risk Myelodysplastic Syndromes in Spain
- Effects of Transfusion of Older Stored Red Cells (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Reb blood cell transfusion CI brief — competitive landscape report
- Reb blood cell transfusion updates RSS · CI watch RSS
- Bristol-Myers Squibb portfolio CI